バイオ医薬品における人工知能（AI）市場レポート：2023-2033
Artificial Intelligence (AI) in Biopharmaceuticals Market Report 2023-2033
レポート詳細
バイオ医薬品における人工知能（AI）市場レポート 2023-2033 ：本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にある力学をより深く理解する上で貴重なものと... もっと見る
※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
サマリー
レポート詳細
バイオ医薬品における人工知能（AI）市場レポート 2023-2033：本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にある力学をより深く理解する上で貴重なものとなろう。異業種への進出や、新たな地域での既存事業の拡大を希望する企業にとっても有用であろう。
AIを活用した医薬品開発に向けた組織間の協力の増加
大手製薬会社の最先端AI技術に大きな変化が起きている。2015年以来、人工知能に対する世間のイメージは、懐疑的なものから慎重な関心、そしてAIがイノベーションの新しい「データ中心」モデルにおいて重要な役割を果たすという認識へと、明らかに変化してきた。この認識の変化は、以下のような多くの要素によって支えられている： - AIの様々な応用事例における研究発見と概念実証の急増 - AIを研究の重要な要素として組み込んだ数多くの商業的成功と成功裏に達成されたマイルストーン。例えば、2023年3月、Exscientia PLCはCharité - Universitätsmedizin Berlin(ドイツ)との提携を発表し、血液がんにおけるAI主導の精密医療プラットフォームを採用した。2023年2月、アルファベットのプレシジョン・ヘルス企業であるベリリーと大塚製薬開発・商業化株式会社（大塚製薬）は、大うつ病性障害（MDD）患者の治療法を検討する臨床試験のための新しい手法で協力すると発表した。
相互運用性システムの開発は、市場にとってチャレンジングな要素である
有線・無線ネットワークを通じて共有データを通信・解読するシステムや機器の能力は、相互運用性と呼ばれる。バイオ医薬品事業を含む医療エコシステムに関わるすべての関係者にとって、これは深刻な課題となっている。バイオ医薬品事業の大半は、多様なITシステムとともに多くの地域にまたがって事業を展開しており、医療機関やその他のパートナーが使用する広範なITシステムからの情報へのアクセスを必要としています。相互運用性を確保するためには、機器とITシステム間、データとワークフロー間の接続と通信を確立する能力が必要です。これは、安全で透明性の高いデータ交換を可能にするコンセンサス標準とプロトコルを使用することで実現される。
バイオ医薬品のバリューチェーン全体は、相互運用可能な技術の開発、特に同意に基づく患者データ共有の分野で改善されなければなりません。他の多くの用途の中でも、相互運用性は、臨床医や患者とのコミュニケーションをより効果的に行い、サプライチェーンにおける品目の追跡・追跡能力を強化し、臨床判断支援を強化し、患者の所在を特定し、薬剤アドヒアランスを強化する上で、ビジネスを支援することができます。ワークフローの効率とパフォーマンスを高め、サイロ化を解消するためには、相互運用性が必要です。
市場調査レポートを購入する前にすべき質問とは？
- バイオ医薬品における人工知能市場はどのように進化しているのか？
- バイオ医薬品における人工知能市場の推進要因と阻害要因は何か？
- バイオ医薬品における人工知能の各サブマーケットセグメントは予測期間中にどのように成長し、2033年にはどれくらいの売上を占めるようになるのか？
- 2023年から2033年にかけて、バイオ医薬品における人工知能の各サブマーケットの市場シェアはどのように推移するのか？
- 2023年から2033年にかけて市場全体を牽引する主な要因は何か？
- バイオ医薬品における人工知能の主要市場はマクロ経済の動きに概ね追随するのか、それとも個々の国市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、2033年に市場をリードするのはどの地域か？
- 主要プレイヤーは誰で、予測期間中の見通しは？
- これらの主要企業におけるバイオ医薬品における人工知能プロジェクトとは？
- 2023年から2033年の間に、業界はどのように進化するのか？バイオ医薬品における人工知能プロジェクトは現在、そして今後10年間でどのような意味を持つのか？
- バイオ医薬品における人工知能市場をさらに拡大するために、製品の商業化の必要性は高まっているか？
- バイオ医薬品における人工知能市場はどこに向かっているのか、そしてどのようにすれば市場の最前線に立つことができるのか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新たな成長路線とC-suiteに移行させるための重要な展望とは？
このことが、現在、そして今後10年間のバイオ医薬品におけるAI市場にどのような影響を与えるかを見極める必要がある：
- 218ページにわたる本レポートでは、90の表と137の図表を掲載しています。
- 本レポートは、業界における主要な有利分野にハイライトを当てているため、今すぐターゲットを絞ることができます。
- 世界、地域、国の売上と成長に関する詳細な分析が含まれています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。
本レポートは、バイオ医薬品における人工知能市場が今後10年間でどのように発展するか、またCOVID-19の景気後退と好転の変動に合わせてTODAYを伝えます。この市場は、過去10年間のどの時点よりも今が重要である。
2033年までの予測やその他の分析から、商業的な展望が明らかになる
- 2033年までの収益予測に加え、直近の業績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望と展開に関する独自の分析をご覧いただけます。
- 定性的分析（市場ダイナミクス、促進要因、機会、阻害要因、課題を含む）、コスト構造、バイオ医薬品における人工知能の価格上昇の影響、最近の動向をご覧いただけます。
このレポートには、COVID-19が業界と貴社にどのような影響を与えるかについてのデータ分析と貴重な洞察が含まれています。
レポート対象セグメント
技術展望
- ディープラーニング
- 自然言語処理
- 画像処理
- その他の技術
用途
- ビジネスプロセスとサプライチェーン
- 創薬
- メディカル・イメージング＆診断
- 精密医療
エンドユーザー
- メーカー
- 受託研究機関
- 学術・政府研究機関
世界市場全体と各分野の売上予測に加え、5つの地域と17の主要国市場の売上予測も掲載しています：
北米
- アメリカ
- カナダ
欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- ロシア
- その他の欧州
アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ
MEA
- GCC
- 南アフリカ
- その他のMEA
本レポートでは、バイオ医薬品における人工知能市場の2023年から2033年までの主要企業のプロファイルも掲載しており、これらの企業の事業のこのセグメントに焦点を当てている。
主要企業と市場成長の可能性
・ Alphabet Inc.
・ Amgen Inc.
・ ConcertAI
・ Exscientia
・ Insilico Medicine
・ Merative (IBM)
・ Microsoft
・ NVIDIA Corporation
・ Schrödinger, Inc.
・ Tencent
2023年から2033年までのバイオ医薬品市場におけるAIの世界全体の売上高は、金額ベースで2023年に493億米ドルを突破する。2033年まで力強い収益成長を予測している。当社の調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的展望を発見し、一歩先を行くお手伝いをします。
バイオ医薬品におけるAI市場、2023-2033年レポートはどのように役立つのか？
要約すると、210ページを超えるこのレポートは、以下の知識を提供する：
- バイオ医薬品における人工知能市場の2023年から2033年までの収益予測 技術、用途、エンドユーザー別の予測を世界レベルと地域レベルで掲載 - 業界の将来性を発見し、投資と収益に最も有利な場所を見つけることができます。
- 5つの地域と17の主要国市場の2033年までの収益予測 - 北米、欧州、アジア太平洋、中南米、MEAにおけるバイオ医薬品における人工知能市場の2023年から2033年までの予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの著名経済圏の市場も予測しています。
- 既存企業および市場参入を目指す企業の展望 - バイオ医薬品における人工知能市場（2023年～2033年）に関わる主要企業10社の企業プロファイルを含む。
独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。
他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性が低くなります。弊社のレポートが貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、バイオ医薬品におけるAI市場、2023年から2033年、市場をリードする企業の商業的分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。
ページTOPに戻る
目次
目次
1 レポート概要
1.1 研究の目的
1.2 はじめに
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて
2 エグゼクティブ・サマリー
3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場促進要因
3.2.1.1 創薬開発の自動化
3.2.1.2 AIを活用したバイオ医薬品におけるより優れたデータ分析とパターン認識が技術採用を促進する
3.2.1.3 特許切れによるAI主導開発の機会創出
3.2.2 市場抑制要因
3.2.2.1 相互運用性システムの開発が市場の挑戦的要因に
3.2.2.2 データプライバシーとセキュリティ
3.2.3 市場機会
3.2.3.1 AIを活用した医薬品開発に向けた組織間連携の増加
3.2.3.2 インドはバイオテクノロジーへの投資で最も有利な国の一つになる
3.3 COVID-19インパクト分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーの交渉力
3.4.2 買い手の交渉力
3.4.3 競争相手のライバル関係
3.4.4 代替品による脅威
3.4.5 新規参入企業の脅威
3.5 PEST分析
4 バイオ医薬品における人工知能市場分析：技術別
4.1 主要な調査結果
4.2 技術セグメント 市場魅力度指数
4.3 バイオ医薬品における人工知能の技術別市場規模推定と予測
4.4 ディープラーニング
4.4.1 2023〜2033年の地域別市場規模（US$ Million）
4.4.2 地域別市場シェア、2023年・2033年(%)
4.5 自然言語処理（NLP）
4.5.1 2023～2033年の地域別市場規模（US$ Million）
4.5.2 地域別市場シェア、2023年・2033年(%)
4.6 画像処理
4.6.1 2023～2033年の地域別市場規模（US$ Million）
4.6.2 地域別市場シェア、2023年・2033年(%)
4.7 その他の技術
4.7.1 2023～2033年の地域別市場規模（US$ Million）
4.7.2 地域別市場シェア、2023年・2033年(%)
5 バイオ医薬品における人工知能市場分析：用途別
5.1 主要な調査結果
5.2 用途別セグメント 市場魅力度指数
5.3 バイオ医薬品における人工知能の用途別市場規模推定と予測
5.4 ビジネスプロセス＆サプライチェーン
5.4.1 2023〜2033年の地域別市場規模（US$ Million）
5.4.2 地域別市場シェア、2023年・2033年(%)
5.5 創薬
5.5.1 2023〜2033年の地域別市場規模（US$ Million）
5.5.2 地域別市場シェア、2023年・2033年(%)
5.6 医用画像診断分野
5.6.1 2023〜2033年の地域別市場規模（US$ Million）
5.6.2 地域別市場シェア、2023年・2033年(%)
5.7 精密医療
5.7.1 2023〜2033年の地域別市場規模（US$ Million）
5.7.2 地域別市場シェア、2023年・2033年(%)
5.8 リサーチ
5.8.1 2023〜2033年の地域別市場規模（US$ Million）
5.8.2 地域別市場シェア、2023年・2033年(%)
6 バイオ医薬品における人工知能市場分析：エンドユーザー別
6.1 主要調査結果
6.2 エンドユーザーセグメント： 市場魅力度指数
6.3 バイオ医薬品における人工知能のエンドユーザー別市場規模推定と予測
6.4 製造業者
6.4.1 2023〜2033年の地域別市場規模（US$ Million）
6.4.2 地域別市場シェア、2023年・2033年(%)
6.5 CRO（医薬品開発業務受託機関）
6.5.1 2023～2033年の地域別市場規模（US$ Million）
6.5.2 地域別市場シェア、2023年・2033年(%)
6.6 学術・政府研究機関
6.6.1 2023～2033年の地域別市場規模（US$ Million）
6.6.2 地域別市場シェア、2023年・2033年(%)
7 バイオ医薬品における人工知能市場分析：地域別
7.1 主要な調査結果
7.2 地域別市場規模の推定と予測
8 北米のバイオ医薬品における人工知能市場分析
8.1 主要な調査結果
8.2 北米のバイオ医薬品における人工知能の市場魅力度指数
8.3 北米のバイオ医薬品における人工知能の国別市場、2023年、2028年、2033年 （US$ Million)
8.4 北米のバイオ医薬品における人工知能市場規模推定と予測：国別
8.5 北米のバイオ医薬品における人工知能市場規模推定と予測：技術別
8.6 北米のバイオ医薬品における人工知能市場規模推定と予測：用途別
8.7 北米のバイオ医薬品における人工知能市場規模推定と予測：エンドユーザー別
8.8 米国のバイオ医薬品における人工知能市場分析
8.9 カナダのバイオ医薬品における人工知能市場分析
9 欧州のバイオ医薬品における人工知能市場分析
9.1 主要な調査結果
9.2 欧州のバイオ医薬品における人工知能市場魅力度指数
9.3 欧州のバイオ医薬品における人工知能の国別市場、2023年、2028年、2033年（US$ Million）
9.4 欧州のバイオ医薬品における人工知能市場規模推定と予測：国別
9.5 欧州のバイオ医薬品における人工知能市場規模推定と予測：技術別
9.6 欧州のバイオ医薬品における人工知能市場規模推定と予測：用途別
9.7 欧州のバイオ医薬品における人工知能市場規模推定と予測：エンドユーザー別
9.8 ドイツのバイオ医薬品における人工知能市場分析
9.9 フランスのバイオ医薬品における人工知能市場分析
9.10 イギリスのバイオ医薬品における人工知能市場分析
9.11 イタリアのバイオ医薬品における人工知能市場分析
9.12 スペインのバイオ医薬品における人工知能市場分析
9.13 ロシアのバイオ医薬品における人工知能市場分析
9.14 その他の欧州のバイオ医薬品における人工知能市場の分析
10 アジア太平洋地域のバイオ医薬品における人工知能市場分析
10.1 主要な調査結果
10.2 アジア太平洋地域のバイオ医薬品における人工知能市場魅力度指数
10.3 アジア太平洋地域のバイオ医薬品における人工知能の国別市場、2023年、2028年、2033年（US$ Million）
10.4 アジア太平洋地域のバイオ医薬品における人工知能市場規模推定と予測：国別
10.5 アジア太平洋地域のバイオ医薬品における人工知能市場規模推定と予測：技術別
10.6 アジア太平洋地域のバイオ医薬品における人工知能市場規模推定と予測：用途別
10.7 アジア太平洋地域のバイオ医薬品における人工知能市場規模推定と予測：エンドユーザー別
10.8 日本のバイオ医薬品における人工知能市場分析
10.9 中国のバイオ医薬品における人工知能市場分析
10.10 インドのバイオ医薬品における人工知能市場分析
10.11 オーストラリアのバイオ医薬品における人工知能市場分析
10.12 韓国のバイオ医薬品における人工知能市場分析
10.13 その他のアジア太平洋地域のバイオ医薬品における人工知能市場分析
11 ラテンアメリカのバイオ医薬品における人工知能市場分析
11.1 主要な調査結果
11.2 ラテンアメリカのバイオ医薬品における人工知能市場魅力度指数
11.3 ラテンアメリカのバイオ医薬品における人工知能の国別市場、2023年、2028年、2033年（US$ Million）
11.4 ラテンアメリカのバイオ医薬品における人工知能市場規模推定と予測：国別
11.5 ラテンアメリカのバイオ医薬品における人工知能市場規模推定と予測：技術別
11.6 ラテンアメリカのバイオ医薬品における人工知能市場規模推定と予測：用途別
11.7 ラテンアメリカのバイオ医薬品における人工知能市場規模推定と予測：エンドユーザー別
11.8 ブラジルのバイオ医薬品における人工知能市場分析
11.9 メキシコのバイオ医薬品における人工知能市場分析
11.10 その他のラテンアメリカのバイオ医薬品における人工知能市場分析
12 MEAのバイオ医薬品における人工知能
12.1 主要な調査結果
12.2 MEAのバイオ医薬品における人工知能市場魅力度指数
12.3 MEAのバイオ医薬品における人工知能国別市場、2023年、2028年、2033年（US$ Million）
12.4 MEAのバイオ医薬品における人工知能市場規模推定と予測：国別
12.5 MEAのバイオ医薬品における人工知能市場規模推定と予測：技術別
12.6 MEAのバイオ医薬品における人工知能市場規模推定と予測：用途別
12.7 MEAのバイオ医薬品における人工知能市場規模推定と予測：エンドユーザー別
12.8 GCCのバイオ医薬品における人工知能市場分析
12.9 南アフリカのバイオ医薬品における人工知能市場分析
12.10 その他のMEAのバイオ医薬品における人工知能市場分析
13 企業のプロフィール
13.1 競争環境、2022年
13.2 戦略的展望
13.3 Microsoft
13.3.1 会社概要
13.3.2 会社概要
13.3.3 財務分析
13.3.3.1 純収入、2017-2022年
13.3.3.2 R＆D、2017-2022年
13.3.3.3 地域市場シェア、2022年
13.3.4 製品・ソリューションベンチマーキング
13.3.5 戦略的展望
13.4 NVIDIA Corporation
13.4.1 会社概要
13.4.2 会社概要
13.4.3 財務分析
13.4.3.1 純収入、2017-2022年
13.4.3.2 R＆D、2017-2022年
13.4.3.3 地域市場シェア、2022年
13.4.4 ソリューションベンチマーキング
13.4.5 戦略的展望
13.5 Alphabet Inc.
13.5.1 会社概要
13.5.2 会社概要
13.5.3 財務分析
13.5.3.1 純収入、2017-2022年
13.5.3.2 R＆D、2017年〜2022年
13.5.3.3 地域市場シェア、2022年
13.5.4 ソリューションベンチマーキング
13.5.5 戦略的展望
13.6 Amgen Inc.
13.6.1 会社概要
13.6.2 会社概要
13.6.3 財務分析
13.6.3.1 純収入、2017-2022年
13.6.3.2 R＆D、2017-2022年
13.6.3.3 地域市場シェア、2022年
13.6.4 ソリューションベンチマーキング
13.6.5 戦略的展望
13.7 Merative ( previously IBM)
13.7.1 会社概要
13.7.2 会社概要
13.7.3 財務分析
13.7.3.1 純収入、2017-2022年
13.7.3.2 R＆D、2017年～2022年
13.7.3.3 地域市場シェア、2022年
13.7.4 ソリューションベンチマーキング
13.7.5 戦略的展望
13.8 Tencent
13.8.1 会社概要
13.8.2 会社概要
13.8.3 財務分析
13.8.3.1 純収入、2018-2022年
13.8.4 ソリューションベンチマーキング
13.9 Exscientia PLC
13.9.1 会社概要
13.9.2 会社概要
13.9.3 財務分析
13.9.3.1 純収入、2020-2022年
13.9.3.2 地域市場シェア（2021年
13.9.4 ソリューションベンチマーキング
13.9.5 戦略的展望
13.10 Schrödinger, Inc.
13.10.1 会社概要
13.10.2 会社概要
13.10.3 財務分析
13.10.3.1 純収入、2018-2022年
13.10.3.2 売上高、2017-2022年
13.10.4 ソリューションベンチマーキング
13.10.5 戦略的展望
13.11 Insilico Medicine
13.11.1 会社概要
13.11.2 会社概要
13.11.3 ソリューション・ベンチマーキング
13.11.4 戦略的展望
13.12 ConcertAI
13.12.1 会社概要
13.12.2 会社概要
13.12.3 ソリューションベンチマーキング
13.12.4 戦略的展望
14 結論と提言
14.1 Visiongainからの結びの言葉
14.2 市場プレイヤーへの提言
ページTOPに戻る
図表リスト
表の一覧
Table 1 Artificial Intelligence in Biopharmaceutical Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 Biotechnology R&D Expenditures in the sector by OECD countries, 2016-2020
Table 3 Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 4 Deep Learning Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 5 NLP Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 6 Image Processing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Other Technologies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Business Process & Supply Chain Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Drug Discovery Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 11 Medical Imaging & Diagnostics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 12 Precision Medicine Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 15 Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 CROs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Academic & Government Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Artificial Intelligence in Biopharmaceutical Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 North America Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Top U.S. Biotech Funding in 2022
Table 24 U.S. Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 25 Canada Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 26 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 27 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 29 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 Germany Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 31 France Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 32 U.K. Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 33 Italy Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 34 Spain Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Russia Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Rest of Europe Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 37 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Japan Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 42 China Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 43 India Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 44 Australia Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 South Korea Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Rest of Asia-Pacific Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 47 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Brazil Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Mexico Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Rest of Latin America Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 GCC Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 South Africa Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Rest of MEA Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 61 Top Company Share Analysis, 2022
Table 62 Strategic Outlook
Table 63 Microsoft: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 64 Microsoft: Product & Solution Benchmarking
Table 65 Microsoft: Strategic Outlook
Table 66 NVIDIA Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 67 NVIDIA Corporation: Solution Benchmarking
Table 68 NVIDIA Corporation: Strategic Outlook
Table 69 Alphabet Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 70 Alphabet Inc.: Solution Benchmarking
Table 71 Alphabet Inc.: Strategic Outlook
Table 72 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 73 Amgen Inc.: Solution Benchmarking
Table 74 Amgen: Strategic Outlook
Table 75 Merative (IBM): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Merative (IBM): Solution Benchmarking
Table 77 Merative (IBM): Strategic Outlook
Table 78 Tencent.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Tencent: Solution Benchmarking
Table 80 Exscientia PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Exscientia PLC: Solution Benchmarking
Table 82 Exscientia PLC: Strategic Outlook
Table 83 Schrödinger, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Schrödinger, Inc: Solution Benchmarking
Table 85 Schrödinger, Inc: Strategic Outlook
Table 86 Insilico Medicine: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Insilico Medicine: Solution Benchmarking
Table 88 Insilico Medicine: Strategic Outlook
Table 89 ConcertAI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 ConcertAI: Solution Benchmarking
Table 91 ConcertAI: Strategic Outlook
図の一覧
Figure 1 Artificial Intelligence in Biopharmaceutical Market Segmentation
Figure 2 Artificial Intelligence in Biopharmaceutical Market by Technology: Market Attractiveness Index
Figure 3 Artificial Intelligence in Biopharmaceutical Market by Application: Market Attractiveness Index
Figure 4 Artificial Intelligence in Biopharmaceutical Market by End-users: Market Attractiveness Index
Figure 5 Artificial Intelligence in Biopharmaceutical Market Attractiveness Index by Region
Figure 6 Artificial Intelligence in Biopharmaceutical Market Dynamics
Figure 7 Global AI in Healthcare Market Trend, 2022 – 2030
Figure 8 Artificial Intelligence in Biopharmaceutical Market: Porter’s Five Forces Analysis
Figure 9 Artificial Intelligence in Biopharmaceutical Market: PEST Analysis
Figure 10 Artificial Intelligence in Biopharmaceutical Market by Technology: Market Attractiveness Index
Figure 11 Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 12 Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023, 2028, 2033 (%)
Figure 13 Deep Learning Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 14 Deep Learning Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 15 NLP Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 16 NLP Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 Image Processing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Image Processing Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Other Technologies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Other Technologies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Artificial Intelligence in Biopharmaceutical Market by Application: Market Attractiveness Index
Figure 22 Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 23 Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023, 2028, 2033 (%)
Figure 24 Business Process & Supply Chain Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 25 Business Process & Supply Chain Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Drug Discovery Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 27 Drug Discovery Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Medical Imaging & Diagnostics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 29 NLP Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Precision Medicine Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 31 Precision Medicine Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Research Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Artificial Intelligence in Biopharmaceutical Market by End-users: Market Attractiveness Index
Figure 35 Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 36 Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 37 Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 38 Manufacturers Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 CROs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 CROs Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Academic & Government Research Institutes Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 Academic & Government Research Institutes Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Artificial Intelligence in Biopharmaceutical Market Forecast by Region 2023 and 2033 (Revenue, CAGR %)
Figure 44 Artificial Intelligence in Biopharmaceutical Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 45 Artificial Intelligence in Biopharmaceutical Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 46 North America Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 47 North America Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 48 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 49 North America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 50 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 51 North America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 52 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 53 North America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 54 North America Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 55 North America Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 56 U.S. Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 57 Canada Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 58 Europe Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 59 Europe Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 60 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 61 Europe Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 62 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 63 Europe Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 64 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 65 Europe Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 66 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 67 Europe Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 68 Germany Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 69 France Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 70 U.K. Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 71 Italy Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 72 Spain Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 73 Russia Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 74 Rest of Europe Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 75 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 76 Asia Pacific Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 77 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 78 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 79 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 80 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 81 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 82 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 83 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 84 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 85 Japan Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 86 China Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 India Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 Australia Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 89 South Korea Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 90 Rest of Asia-Pacific Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 91 Latin America Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 92 Latin America Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 93 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 94 Latin America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 95 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 96 Latin America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 97 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 98 Latin America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 99 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 100 Latin America Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 101 Brazil Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 102 Mexico Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 103 Rest of Latin America Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 MEA Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 105 MEA Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 106 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 107 MEA Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 108 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 109 MEA Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 110 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 111 MEA Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 112 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 113 MEA Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 114 GCC Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 115 South Africa Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 116 Rest of MEA Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 117 Artificial Intelligence in Biopharmaceutical Market: Company Share, 2022
Figure 118 Microsoft: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 119 Microsoft: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 120 Microsoft: Regional Market Shares, 2022
Figure 121 NVIDIA Corporation: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 122 NVIDIA Corporation: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 123 NVIDIA Corporation: Regional Market Shares, 2022
Figure 124 Alphabet Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 125 Alphabet Inc.: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 126 Alphabet Inc.: Regional Market Shares, 2022
Figure 127 Amega Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 128 Amgen Inc.: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 129 Amgen Inc.: Regional Market Shares, 2022
Figure 130 Merative (IBM): Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 131 Merative (IBM): R&D, 2017-2022 (US$ Billion, AGR%)
Figure 132 Merative (IBM): Regional Market Shares, 2022
Figure 133 Tencent.: Net Revenue, 2018-2022 (US$ Billion, AGR%)
Figure 134 Exscientia PLC: Net Revenue, 2020-2022 (US$ Million, AGR%)
Figure 135 Exscientia PLC.: Regional Market Shares, 2021
Figure 136 Schrödinger, Inc.: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 137 Schrödinger, Inc: R&D, 2018-2022 (US$ Billion, AGR%)
ページTOPに戻る
Summary
Report Details
The Artificial Intelligence (AI) in Biopharmaceuticals Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increasing collaborations among organizations towards drug development enabled by AI
There has been a significant shift in cutting-edge AI technologies at big pharmaceutical companies. Since 2015, there has been a clear change in the public’s image of artificial intelligence, from skepticism to cautious interest to the realization that AI plays a vital role in the new “data-centric” model of innovation. This shift in perception was supported by a number of elements, including: – a flurry of research discoveries and proof-of-concept studies in a variety of AI application use cases; – a number of commercial successes and successfully attained milestones incorporating AI as a key component of research. For instance, in March 2023, Exscientia PLC announced collaboration with Charité – Universitätsmedizin Berlin (Germany) to adopt AI-driven precision medicine platform in haematological cancers. In February 2023, Verily, an Alphabet precision health company, and Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) announced that they are collaborating on novel methods for clinical trials looking at therapies for individuals with Major Depressive Disorder (MDD).
Developing interoperability systems is a challenging factor for the market
The capacity of systems and gadgets to communicate and decipher shared data through wired and wireless networks is referred to as interoperability. For all parties involved in the health care ecosystem, including biopharma businesses, it poses a serious challenge. The majority of biopharmaceutical businesses operate across many geographies with numerous diverse IT systems and require access to information from a wide range of IT systems used by healthcare organisations and other partners. The capacity to establish connectivity and communication between devices and IT systems, as well as between data and workflows, is necessary for interoperability. This is done by using consensus standards and protocols to enable secure and transparent data exchange.
The entire biopharma value chain must be improved through the development of interoperable technologies, especially in the area of patient data sharing with consent. Among many other uses, interoperability can assist businesses in communicating with clinicians and patients more effectively, enhancing the supply chain’s ability to track and trace items, enhancing clinical decision support, locating patients, and enhancing drug adherence. To increase workflow efficiency and performance and to eliminate siloes behaviour, interoperability is required.
What Questions Should You Ask before Buying a Market Research Report?
• How is the AI in Biopharmaceutical market evolving?
• What is driving and restraining the AI in Biopharmaceutical market?
• How will each AI in Biopharmaceutical submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each AI in Biopharmaceutical submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading AI in Biopharmaceutical markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the AI in Biopharmaceutical projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of AI in Biopharmaceutical projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the AI in Biopharmaceutical market?
• Where is the AI in Biopharmaceutical market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the AI in Biopharmaceutical market today, and over the next 10 years:
• Our 218-page report provides 90 tables and 137 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the AI in Biopharmaceutical market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising AI in Biopharmaceutical prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company.
Segments Covered in the Report
Technology Outlook
• Deep Learning
• NLP
• Image Processing
• Other Technologies
Application
• Business Process & Supply Chain
• Drug Discovery
• Medical Imaging & Diagnostics
• Precision Medicine
End-users
• Manufacturers
• Contract Research Organizations
• Academic & Government Research Institutes
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 17 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the AI in Biopharmaceutical Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Alphabet Inc.
• Amgen Inc.
• ConcertAI
• Exscientia
• Insilico Medicine
• Merative (IBM)
• Microsoft
• NVIDIA Corporation
• Schrödinger, Inc.
• Tencent
Overall world revenue for AI in Biopharmaceutical Market, 2023 to 2033 in terms of value the market will surpass US$49.3 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the AI in Biopharmaceutical Market, 2023 to 2033 report help you?
In summary, our 210+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for AI in Biopharmaceutical Market, 2023 to 2033 Market, with forecasts for technology, application, and end-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 17 key national markets – See forecasts for the AI in Biopharmaceutical Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the AI in Biopharmaceutical Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the AI in Biopharmaceutical Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
ページTOPに戻る
Table of Contents
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Automation in Drug Discovery and development
3.2.1.2 Better data analysis and pattern recognition in biopharma with AI to drive the technology adoption
3.2.1.3 Patent expiry to create opportunity for AI-driven development
3.2.2 Market Restraining Factors
3.2.2.1 Developing interoperability systems is a challenging factor for the market
3.2.2.2 Data Privacy and security
3.2.3 Market Opportunities
3.2.3.1 Increasing collaborations among organizations towards drug development enabled by AI
3.2.3.2 India to be one of the most lucrative countries for investment in biotechnologies
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Artificial Intelligence in Biopharmaceutical Market Analysis by Technology
4.1 Key Findings
4.2 Technology Segment: Market Attractiveness Index
4.3 Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Technology
4.4 Deep Learning
4.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Natural Language Processing (NLP)
4.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Image Processing
4.6.1 Market Size by Region, 2023-2033 (US$ Million)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Other Technologies
4.7.1 Market Size by Region, 2023-2033 (US$ Million)
4.7.2 Market Share by Region, 2023 & 2033 (%)
5 Artificial Intelligence in Biopharmaceutical Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Application
5.4 Business Process & Supply Chain
5.4.1 Market Size by Region, 2023-2033 (US$ Million)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Drug Discovery
5.5.1 Market Size by Region, 2023-2033 (US$ Million)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Medical Imaging & Diagnostics
5.6.1 Market Size by Region, 2023-2033 (US$ Million)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Precision Medicine
5.7.1 Market Size by Region, 2023-2033 (US$ Million)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Research
5.8.1 Market Size by Region, 2023-2033 (US$ Million)
5.8.2 Market Share by Region, 2023 & 2033 (%)
6 Artificial Intelligence in Biopharmaceutical Market Analysis by End-users
6.1 Key Findings
6.2 End-users Segment: Market Attractiveness Index
6.3 Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by End-users
6.4 Manufacturers
6.4.1 Market Size by Region, 2023-2033 (US$ Million)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Contract Research Organizations (CROs)
6.5.1 Market Size by Region, 2023-2033 (US$ Million)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Academic & Government Research Institutes
6.6.1 Market Size by Region, 2023-2033 (US$ Million)
6.6.2 Market Share by Region, 2023 & 2033 (%)
7 Artificial Intelligence in Biopharmaceutical Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
8 North America Artificial Intelligence in Biopharmaceutical Market Analysis
8.1 Key Findings
8.2 North America Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
8.3 North America Artificial Intelligence in Biopharmaceutical Market by Country, 2023, 2028 & 2033 (US$ Million)
8.4 North America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Country
8.5 North America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Technology
8.6 North America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Application
8.7 North America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by End-users
8.8 U.S. Artificial Intelligence in Biopharmaceutical Market Analysis
8.9 Canada Artificial Intelligence in Biopharmaceutical Market Analysis
9 Europe Artificial Intelligence in Biopharmaceutical Market Analysis
9.1 Key Findings
9.2 Europe Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
9.3 Europe Artificial Intelligence in Biopharmaceutical Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 Europe Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Country
9.5 Europe Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Technology
9.6 Europe Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Application
9.7 Europe Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by End-users
9.8 Germany Artificial Intelligence in Biopharmaceutical Market Analysis
9.9 France Artificial Intelligence in Biopharmaceutical Market Analysis
9.10 U.K. Artificial Intelligence in Biopharmaceutical Market Analysis
9.11 Italy Artificial Intelligence in Biopharmaceutical Market Analysis
9.12 Spain Artificial Intelligence in Biopharmaceutical Market Analysis
9.13 Russia Artificial Intelligence in Biopharmaceutical Market Analysis
9.14 Rest of Europe Artificial Intelligence in Biopharmaceutical Market Analysis
10 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Analysis
10.1 Key Findings
10.2 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
10.3 Asia Pacific Artificial Intelligence in Biopharmaceutical Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Country
10.5 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Technology
10.6 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Application
10.7 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by End-users
10.8 Japan Artificial Intelligence in Biopharmaceutical Market Analysis
10.9 China Artificial Intelligence in Biopharmaceutical Market Analysis
10.10 India Artificial Intelligence in Biopharmaceutical Market Analysis
10.11 Australia Artificial Intelligence in Biopharmaceutical Market Analysis
10.12 South Korea Artificial Intelligence in Biopharmaceutical Market Analysis
10.13 Rest of Asia-Pacific Artificial Intelligence in Biopharmaceutical Market Analysis
11 Latin America Artificial Intelligence in Biopharmaceutical Market Analysis
11.1 Key Findings
11.2 Latin America Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
11.3 Latin America Artificial Intelligence in Biopharmaceutical Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Latin America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Country
11.5 Latin America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Technology
11.6 Latin America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Application
11.7 Latin America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by End-users
11.8 Brazil Artificial Intelligence in Biopharmaceutical Market Analysis
11.9 Mexico Artificial Intelligence in Biopharmaceutical Market Analysis
11.10 Rest of Latin America Artificial Intelligence in Biopharmaceutical Market Analysis
12 MEA Artificial Intelligence in Biopharmaceutical
12.1 Key Findings
12.2 MEA Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
12.3 MEA Artificial Intelligence in Biopharmaceutical Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 MEA Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Country
12.5 MEA Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Technology
12.6 MEA Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Application
12.7 MEA Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by End-users
12.8 GCC Artificial Intelligence in Biopharmaceutical Market Analysis
12.9 South Africa Artificial Intelligence in Biopharmaceutical Market Analysis
12.10 Rest of MEA Artificial Intelligence in Biopharmaceutical Market Analysis
13 Company Profiles
13.1 Competitive Landscape, 2022
13.2 Strategic Outlook
13.3 Microsoft
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2022
13.3.3.2 R&D, 2017-2022
13.3.3.3 Regional Market Shares, 2022
13.3.4 Product & Solution Benchmarking
13.3.5 Strategic Outlook
13.4 NVIDIA Corporation
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2022
13.4.3.2 R&D, 2017-2022
13.4.3.3 Regional Market Shares, 2022
13.4.4 Solution Benchmarking
13.4.5 Strategic Outlook
13.5 Alphabet Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2017-2022
13.5.3.2 R&D, 2017-2022
13.5.3.3 Regional Market Shares, 2022
13.5.4 Solution Benchmarking
13.5.5 Strategic Outlook
13.6 Amgen Inc.
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2017-2022
13.6.3.2 R&D, 2017-2022
13.6.3.3 Regional Market Shares, 2022
13.6.4 Solution Benchmarking
13.6.5 Strategic Outlook
13.7 Merative ( previously IBM)
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2017-2022
13.7.3.2 R&D, 2017-2022
13.7.3.3 Regional Market Shares, 2022
13.7.4 Solution Benchmarking
13.7.5 Strategic Outlook
13.8 Tencent
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2018-2022
13.8.4 Solution Benchmarking
13.9 Exscientia PLC
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2020-2022
13.9.3.2 Regional Market Shares, 2021
13.9.4 Solution Benchmarking
13.9.5 Strategic Outlook
13.10 Schrödinger, Inc.
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2018-2022
13.10.3.2 R&D, 2017-2022
13.10.4 Solution Benchmarking
13.10.5 Strategic Outlook
13.11 Insilico Medicine
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Solution Benchmarking
13.11.4 Strategic Outlook
13.12 ConcertAI
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Solution Benchmarking
13.12.4 Strategic Outlook
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
ページTOPに戻る
List of Tables/Graphs
List of Tables
Table 1 Artificial Intelligence in Biopharmaceutical Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 Biotechnology R&D Expenditures in the sector by OECD countries, 2016-2020
Table 3 Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 4 Deep Learning Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 5 NLP Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 6 Image Processing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Other Technologies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Business Process & Supply Chain Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Drug Discovery Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 11 Medical Imaging & Diagnostics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 12 Precision Medicine Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 15 Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 CROs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Academic & Government Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Artificial Intelligence in Biopharmaceutical Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 North America Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Top U.S. Biotech Funding in 2022
Table 24 U.S. Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 25 Canada Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 26 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 27 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 29 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 Germany Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 31 France Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 32 U.K. Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 33 Italy Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 34 Spain Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Russia Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Rest of Europe Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 37 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Japan Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 42 China Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 43 India Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 44 Australia Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 South Korea Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Rest of Asia-Pacific Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 47 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Brazil Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Mexico Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Rest of Latin America Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 GCC Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 South Africa Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Rest of MEA Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 61 Top Company Share Analysis, 2022
Table 62 Strategic Outlook
Table 63 Microsoft: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 64 Microsoft: Product & Solution Benchmarking
Table 65 Microsoft: Strategic Outlook
Table 66 NVIDIA Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 67 NVIDIA Corporation: Solution Benchmarking
Table 68 NVIDIA Corporation: Strategic Outlook
Table 69 Alphabet Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 70 Alphabet Inc.: Solution Benchmarking
Table 71 Alphabet Inc.: Strategic Outlook
Table 72 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 73 Amgen Inc.: Solution Benchmarking
Table 74 Amgen: Strategic Outlook
Table 75 Merative (IBM): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Merative (IBM): Solution Benchmarking
Table 77 Merative (IBM): Strategic Outlook
Table 78 Tencent.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Tencent: Solution Benchmarking
Table 80 Exscientia PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Exscientia PLC: Solution Benchmarking
Table 82 Exscientia PLC: Strategic Outlook
Table 83 Schrödinger, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Schrödinger, Inc: Solution Benchmarking
Table 85 Schrödinger, Inc: Strategic Outlook
Table 86 Insilico Medicine: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Insilico Medicine: Solution Benchmarking
Table 88 Insilico Medicine: Strategic Outlook
Table 89 ConcertAI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 ConcertAI: Solution Benchmarking
Table 91 ConcertAI: Strategic Outlook
List of Figures
Figure 1 Artificial Intelligence in Biopharmaceutical Market Segmentation
Figure 2 Artificial Intelligence in Biopharmaceutical Market by Technology: Market Attractiveness Index
Figure 3 Artificial Intelligence in Biopharmaceutical Market by Application: Market Attractiveness Index
Figure 4 Artificial Intelligence in Biopharmaceutical Market by End-users: Market Attractiveness Index
Figure 5 Artificial Intelligence in Biopharmaceutical Market Attractiveness Index by Region
Figure 6 Artificial Intelligence in Biopharmaceutical Market Dynamics
Figure 7 Global AI in Healthcare Market Trend, 2022 – 2030
Figure 8 Artificial Intelligence in Biopharmaceutical Market: Porter’s Five Forces Analysis
Figure 9 Artificial Intelligence in Biopharmaceutical Market: PEST Analysis
Figure 10 Artificial Intelligence in Biopharmaceutical Market by Technology: Market Attractiveness Index
Figure 11 Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 12 Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023, 2028, 2033 (%)
Figure 13 Deep Learning Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 14 Deep Learning Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 15 NLP Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 16 NLP Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 Image Processing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Image Processing Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Other Technologies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Other Technologies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Artificial Intelligence in Biopharmaceutical Market by Application: Market Attractiveness Index
Figure 22 Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 23 Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023, 2028, 2033 (%)
Figure 24 Business Process & Supply Chain Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 25 Business Process & Supply Chain Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Drug Discovery Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 27 Drug Discovery Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Medical Imaging & Diagnostics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 29 NLP Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Precision Medicine Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 31 Precision Medicine Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Research Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Artificial Intelligence in Biopharmaceutical Market by End-users: Market Attractiveness Index
Figure 35 Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 36 Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 37 Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 38 Manufacturers Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 CROs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 CROs Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Academic & Government Research Institutes Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 Academic & Government Research Institutes Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Artificial Intelligence in Biopharmaceutical Market Forecast by Region 2023 and 2033 (Revenue, CAGR %)
Figure 44 Artificial Intelligence in Biopharmaceutical Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 45 Artificial Intelligence in Biopharmaceutical Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 46 North America Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 47 North America Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 48 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 49 North America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 50 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 51 North America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 52 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 53 North America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 54 North America Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 55 North America Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 56 U.S. Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 57 Canada Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 58 Europe Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 59 Europe Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 60 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 61 Europe Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 62 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 63 Europe Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 64 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 65 Europe Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 66 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 67 Europe Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 68 Germany Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 69 France Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 70 U.K. Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 71 Italy Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 72 Spain Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 73 Russia Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 74 Rest of Europe Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 75 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 76 Asia Pacific Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 77 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 78 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 79 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 80 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 81 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 82 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 83 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 84 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 85 Japan Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 86 China Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 India Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 Australia Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 89 South Korea Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 90 Rest of Asia-Pacific Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 91 Latin America Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 92 Latin America Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 93 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 94 Latin America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 95 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 96 Latin America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 97 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 98 Latin America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 99 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 100 Latin America Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 101 Brazil Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 102 Mexico Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 103 Rest of Latin America Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 MEA Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 105 MEA Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 106 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 107 MEA Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 108 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 109 MEA Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 110 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 111 MEA Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 112 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 113 MEA Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 114 GCC Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 115 South Africa Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 116 Rest of MEA Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 117 Artificial Intelligence in Biopharmaceutical Market: Company Share, 2022
Figure 118 Microsoft: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 119 Microsoft: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 120 Microsoft: Regional Market Shares, 2022
Figure 121 NVIDIA Corporation: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 122 NVIDIA Corporation: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 123 NVIDIA Corporation: Regional Market Shares, 2022
Figure 124 Alphabet Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 125 Alphabet Inc.: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 126 Alphabet Inc.: Regional Market Shares, 2022
Figure 127 Amega Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 128 Amgen Inc.: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 129 Amgen Inc.: Regional Market Shares, 2022
Figure 130 Merative (IBM): Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 131 Merative (IBM): R&D, 2017-2022 (US$ Billion, AGR%)
Figure 132 Merative (IBM): Regional Market Shares, 2022
Figure 133 Tencent.: Net Revenue, 2018-2022 (US$ Billion, AGR%)
Figure 134 Exscientia PLC: Net Revenue, 2020-2022 (US$ Million, AGR%)
Figure 135 Exscientia PLC.: Regional Market Shares, 2021
Figure 136 Schrödinger, Inc.: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 137 Schrödinger, Inc: R&D, 2018-2022 (US$ Billion, AGR%)
ページTOPに戻る
本レポートと同じKEY WORD（artificial intelligence）の最新刊レポート
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
